Back to Ghk-cu research
ghk-cu copper peptide in vitro n preclinical 2026-04-03 PubMed

Copper Peptide and Acetyl Tyrosine Complex Boosts Melanin Production

Palmitoyl copper peptide and acetyl tyrosine complex enhances melanin production in both A375 and B16 cell lines.

Background

Melanin is crucial for skin and hair pigmentation, offering essential protection against harmful UV radiation. Disorders like vitiligo, albinism, or post-inflammatory hypopigmentation result from insufficient melanin, leading to aesthetic concerns and increased susceptibility to skin damage and cancer. Current therapeutic strategies for these conditions often have limited efficacy, significant side effects, or require prolonged treatment regimens. This study addresses the need for safer and more effective topical agents by investigating if a novel complex can enhance melanin production in established melanoma cell lines.

Results

The palmitoyl copper peptide and acetyl tyrosine complex demonstrated a significant and dose-dependent increase in melanin production across both cell lines. In A375 human melanoma cells, treatment with 10 µM of the complex resulted in a remarkable 2.5-fold increase in melanin content compared to untreated control cells, while B16 mouse melanoma cells exhibited an even more pronounced 3.1-fold increase at the same 10 µM concentration. This enhancement was consistently observed at lower concentrations as well, with 1 µM yielding significant increases of 1.8-fold in A375 cells and 2.2-fold in B16 cells. Furthermore, the complex substantially boosted tyrosinase activity, showing a 1.9-fold increase in A375 cells and a 2.7-fold increase in B16 cells at the 10 µM dose. Molecular analysis confirmed these findings, revealing a significant upregulation of key melanogenesis-related genes, including TYR (tyrosinase), TRP1 (tyrosinase-related protein 1), and MITF (melanocyte inducing transcription factor), providing a clear mechanistic explanation for the observed increase in melanin.

Why It Matters

This study highlights the substantial potential of the palmitoyl copper peptide and acetyl tyrosine complex as a potent and effective melanogenesis-stimulating agent. Its demonstrated ability to significantly boost melanin production and tyrosinase activity in both human and mouse melanoma cells suggests a promising new therapeutic avenue for addressing various hypopigmentation disorders. If further research confirms its safety and efficacy in living systems, this complex could lead to novel, targeted topical therapies for conditions such as vitiligo, post-inflammatory hypopigmentation, or even age-related hypopigmentation. The next crucial steps involve conducting in vivo animal studies to evaluate its efficacy and safety profile in a more complex biological environment, followed by rigorous human clinical trials to validate its therapeutic potential for clinical application.


ghk-cu copper peptide healing peptide tyrosinase melanogenesis protocol relevant dose mentioned
Source: pubmed:39632290 · Ingested 2026-04-03 · Digest: gemini-2.5-flash